Cure Childhood Cancer Inc
- Assets
- $7.8m
- Revenue
- $10.2m
- Investments
- $3.1m
- Employees
- 27
- Location
- Atlanta, GA
- Founding
- 03/1976
- Data as of
- 06/2023
- EIN
- 58-1244138
Organization Overview
Cure Childhood Cancer Inc is located in Atlanta, GA. The organization was established in 1976. As of 06/2023, Cure Childhood Cancer Inc employed 27 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Cure Childhood Cancer Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 06/2023, Cure Childhood Cancer Inc generated $10.2m in total revenue. This represents relatively stable growth, over the past 8 years the organization has increased revenue by an average of 8.9% each year. All expenses for the organization totaled $10.2m during the year ending 06/2023. While expenses have increased by 11.4% per year over the past 8 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Since 2015, Cure Childhood Cancer Inc has awarded 63 individual grants totaling $34,320,761. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
CONQUERING CHILDHOOD CANCER BY FUNDING TARGETED RESEARCH WHILE SUPPORTING PATIENTS AND THEIR FAMILIES.
Describe the Organization's Program Activity:
Part 3 - Line 4a
TO FUND RESEARCH INTO TARGETED TREATMENTS AND CURES FOR CANCERS AFFECTING CHILDREN WHILE PROVIDING TANGIBLE SUPPORT TO CHILDHOOD CANCER PATIENTS AND THEIR FAMILIES AIMED AT ADDRESSING THEIR CRITICAL AND URGENT NEEDS.
EDUCATION - CURE PROVIDES CRITICAL EDUCATION TO FAMILIES OF CHILDREN DIAGNOSED WITH CANCER, ON TREATMENT, AND IN SURVIVORSHIP. CURE TARGETS ELECTRONIC NEWSLETTERS WITH RELEVANT MATERIAL TO EACH GROUP, ENSURING FAMILIES HAVE THE INFORMATION THEY NEED TO NAVIGATE COMPLEX TREATMENT PROTOCOLS AND KNOW HOW TO MONITOR FOR LATE EFFECTS OF CANCER TREATMENTS, MAINTAINS SOCIAL MEDIA PLATFORMS ON WHICH TO SHARE INFORMATION WITH FAMILIES AND OTHERS, AND PROVIDES ROBUST EDUCATION TO THE COMMUNITY AT LARGE ABOUT THE PROBLEM OF CHILDHOOD CANCER, THE NEED FOR RESEARCH FUNDING, CRITICAL WAYS TO HELP FAMILIES FIGHTING CHILDHOOD CANCER, AND IMPORTANT SCIENTIFIC ADVANCEMENTS IN THE FIELD.
PATIENT AND FAMILY SERVICE SUPPORTING PATIENTS AND THEIR FAMILIES THROUGH (1) EARLY OUTREACH ASSISTING FAMILIES WITH A NEW DIAGNOSIS BY PROVIDING PRACTICAL INFORMATION, ENCOURAGEMENT AND ITEMS THAT WILL BE USEFUL AS THEIR CHILD BEGINS TREATMENT, (2) CRITICAL NEEDS CARE ADDRESSES THE CRITICAL AND URGENT NEEDS OF PATIENTS AND FAMILIES BY PROVIDING EMERGENCY FINANCIAL ASSISTANCE, INCLUDING TRANSPORTATION AND LODGING ASSISTANCE, PROFESSIONAL COUNSELING TO PATIENTS, PARENTS AND SIBLINGS, MEALS TO HOSPITALIZED CHILDREN AND CAREGIVERS AND CRITICAL BEREAVEMENT SUPPORT FOR FAMILIES WHO HAVE LOST A CHILD TO CANCER
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Matt Gephardt President | OfficerTrustee | 10 | $0 |
Casey Sentell Vice President | OfficerTrustee | 3 | $0 |
Liz Stanton Vice President | OfficerTrustee | 5 | $0 |
Meredith Sidewater Secretary | OfficerTrustee | 5 | $0 |
Kos Doukov Treasurer | OfficerTrustee | 5 | $0 |
Donna Baker Member | Trustee | 2 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $5,018,448 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $5,885,204 |
| Noncash contributions included in lines 1a–1f | $515,706 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $10,903,652 |
| Total Program Service Revenue | $0 |
| Investment income | $129,040 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $111,068 |
| Net Income from Fundraising Events | -$983,632 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $32,057 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $10,192,185 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $5,005,000 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $310,326 |
| Compensation of current officers, directors, key employees. | $30,356 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $1,991,284 |
| Pension plan accruals and contributions | $0 |
| Other employee benefits | $280,170 |
| Payroll taxes | $161,227 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $0 |
| Fees for services: Accounting | $58,895 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $28,107 |
| Fees for services: Other | $31,800 |
| Advertising and promotion | $353,883 |
| Office expenses | $124,427 |
| Information technology | $124,884 |
| Royalties | $0 |
| Occupancy | $221,010 |
| Travel | $0 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $0 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $11,254 |
| Insurance | $18,156 |
| All other expenses | $22,708 |
| Total functional expenses | $10,238,422 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $0 |
| Savings and temporary cash investments | $2,422,018 |
| Pledges and grants receivable | $11,365 |
| Accounts receivable, net | $14,072 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $14,264 |
| Prepaid expenses and deferred charges | $229,088 |
| Net Land, buildings, and equipment | $108,156 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $3,065,276 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $1,889,112 |
| Total assets | $7,753,351 |
| Accounts payable and accrued expenses | $164,152 |
| Grants payable | $1,650,000 |
| Deferred revenue | $185,447 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $2,043,584 |
| Total liabilities | $4,043,183 |
| Net assets without donor restrictions | $3,665,490 |
| Net assets with donor restrictions | $44,678 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $7,753,351 |
Grants Awarded
Over the last fiscal year, Cure Childhood Cancer Inc has awarded $4,992,304 in support to 10 organizations.
| Grant Recipient | Amount |
|---|---|
CHILDREN'S HEALTHCARE OF ATLANTA FOUNDATION INC PURPOSE: CANCER RESEARCH | $2,242,304 |
CHILDREN'S HOSPITAL BOSTON PURPOSE: CANCER RESEARCH | $330,000 |
LURIE CHILDREN'S HOSPITAL OF CLEVELAND PURPOSE: CANCER RESEARCH | $220,000 |
DANA-FARBER CANCER INSTITUTE PURPOSE: CANCER RESEARCH | $330,000 |
LELAND STANFORD JUNIOR UNIVERSITY PURPOSE: CANCER RESEARCH | $330,000 |
RAINBOW BABIES & CHILDREN'S HOSPITAL PURPOSE: CANCER RESEARCH | $220,000 |